Cargando…

Captopril alleviates lung inflammation in SARS-CoV-2-infected hypertensive mice

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiologic agent responsible for the global coronavirus disease 2019 (COVID-19) pandemic. Numerous studies have demonstrated that cardiovascular disease may affect COVID-19 progression. In the present study, we investigated the effec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Wen-Cong, Ma, Xin, Wang, Peng, He, Xiao-Yan, Zheng, Yong-Tang, Liu, Feng-Liang, Zheng, Chang-Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Science Press 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455464/ https://www.ncbi.nlm.nih.gov/pubmed/34423606 http://dx.doi.org/10.24272/j.issn.2095-8137.2021.206

Ejemplares similares

Captopril alleviates hypertension-induced renal damage, inflammation, and NF-κB activation
por: Gan, Zhongyuan, et al.
Publicado: (2018)

Captopril reduces lung inflammation and accelerated senescence in response to thoracic radiation in mice
por: Mungunsukh, Ognoon, et al.
Publicado: (2021)

Combinational benefit of antihistamines and remdesivir for reducing SARS-CoV-2 replication and alleviating inflammation-induced lung injury in mice
por: Wu, Meng-Li, et al.
Publicado: (2022)

Captopril Alleviates Chondrocyte Senescence in DOCA-Salt Hypertensive Rats Associated with Gut Microbiome Alteration
por: Chan, Lok Chun, et al.
Publicado: (2022)

SARS-CoV-2 induces cardiomyocyte apoptosis and inflammation but can be ameliorated by ACE inhibitor Captopril
por: Huang, Xiaohan, et al.
Publicado: (2023)

Captopril alleviates epilepsy and cognitive impairment by attenuation of C3-mediated inflammation and synaptic phagocytosis
por: Dong, Xinyan, et al.
Publicado: (2022)

Particulate matter exposure exacerbates susceptibility to SARS-CoV-2 infection in humanized ACE2 mice
por: Zhu, Teng-Yu, et al.
Publicado: (2021)

White coat hypertension during the SARS-CoV-2 pandemic
por: Nasiri, Kaveh, et al.
Publicado: (2023)

Effective treatment of SARS-CoV-2-infected rhesus macaques by attenuating inflammation
por: Lu, Shuaiyao, et al.
Publicado: (2020)

SARS‐CoV‐2 spike protein alleviates atherosclerosis by suppressing macrophage lipid uptake through regulating R‐loop formation on MSR1 mRNA
por: Zhao, Wenting, et al.
Publicado: (2021)

Tissue distribution of SARS-CoV-2 in non-human primates after combined intratracheal and intranasal inoculation
por: Song, Tian-Zhang, et al.
Publicado: (2021)

Lactacystin-Induced Model of Hypertension in Rats: Effects of Melatonin and Captopril
por: Simko, Fedor, et al.
Publicado: (2017)

Effects of Captopril and Losartan on Cardiac Stereology in Rats with Renovascular Hypertension
por: Akbar Nekooeian, Ali, et al.
Publicado: (2021)

RUNX1 promotes mitophagy and alleviates pulmonary inflammation during acute lung injury
por: Tang, Xiaoju, et al.
Publicado: (2023)

Hypertensive emergency and intracranial bleed following vaccination against SARS-COV-2 virus
por: Gulabani, Michell, et al.
Publicado: (2022)

RNA editing detection in SARS-CoV-2 transcriptome should be different from traditional SNV identification
por: Cai, Houhao, et al.
Publicado: (2022)

SARS-COV2 Alters Blood Brain Barrier Integrity Contributing to Neuro-Inflammation
por: Reynolds, Jessica. L., et al.
Publicado: (2021)

PQQ Supplementation and SARS-CoV-2 Spike Protein-Induced Heart Inflammation
por: Boretti, Alberto
Publicado: (2022)

Serial semiquantitative detection of SARS-CoV-2 in saliva samples
por: Mao, Ming-Hui, et al.
Publicado: (2021)

Impaired lung regeneration after SARS‐CoV‐2 infection
por: Shao, Hongxia, et al.
Publicado: (2020)

Lung ultrasonography unmasking the asymptomatic SARS-CoV-2 carrier
por: Tung-Chen, Yale, et al.
Publicado: (2021)

Lung ultrasonography unmasking the asymptomatic SARS-CoV-2 carrier
por: Tung-Chen, Yale, et al.
Publicado: (2021)

Viral dynamics during SARS-CoV-2 omicron infection highlight presymptomatic and asymptomatic infectiousness
por: Jiang, Li, et al.
Publicado: (2023)

Effect of sour tea (Lipicom) pill versus captopril on the treatment of hypertension
por: Soleimani, Ali-Reza, et al.
Publicado: (2015)

Humoral immune durability of IgG for anti-SARS-CoV-2 in the normal pregnant women in Wuhan, China
por: Ma, Hongwen, et al.
Publicado: (2021)

SARS-CoV-2 interacts with platelets and megakaryocytes via ACE2-independent mechanism
por: Shen, Shu, et al.
Publicado: (2021)

SARS‐CoV‐2 infection in lung transplant recipients induces circulating exosomes with SARS‐CoV‐2 spike protein S2
por: Bansal, Sandhya, et al.
Publicado: (2021)

The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
por: Xia, Yong, et al.
Publicado: (2020)

Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Assay for the Detection of SARS-CoV-2 in Oropharyngeal Swab Specimens
por: Hou, Hongyan, et al.
Publicado: (2020)

Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection
por: Kong, Qi, et al.
Publicado: (2020)

SARS-CoV-2 as potential cause of cardiac inflammation and heart failure. Is it the virus, hyperinflammation, or MODS?
por: Maisch, Bernhard
Publicado: (2020)

Isolated intracranial hypertension following SARS-CoV-2 infection in an adolescent boy: a case report
por: ELmazny, Alaa, et al.
Publicado: (2021)

Idiopathic Intracranial Hypertension Associated with SARS-CoV-2 B.1.1.7 Variant of Concern
por: Khalid, Muhammad Faran, et al.
Publicado: (2021)

Surface electrostatic shift on spike protein decreased antibody activities against SARS-CoV-2 Omicron variant
por: Yuan, Shu, et al.
Publicado: (2022)

A booster shot of vaccine against SARS-CoV-2 should be rigorously promoted and implemented in China
por: Yin, Yong, et al.
Publicado: (2023)

Hydrogen-rich water alleviates inflammation and fatigue in COVID-19: A pilot study
por: Milovancev, Aleksandra, et al.
Publicado: (2022)

The use of SARS-CoV-2-related coronaviruses from bats and pangolins to polarize mutations in SARS-Cov-2
por: Li, Tao, et al.
Publicado: (2020)

Co-infection of SARS-CoV-2 and Influenza virus in Early Stage of the COVID-19 Epidemic in Wuhan, China
por: Zheng, Xin, et al.
Publicado: (2020)

Comparison of microbial composition and diversity in the upper respiratory tract between SARS-CoV-2 and influenza virus infections
por: Jia, Lijia, et al.
Publicado: (2022)

Abrupt Deterioration of COVID-19 Patients and Spreading of SARS COV-2 Virions in the Lungs
por: Filipovic, N., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_upkhmo2fn4fpa2pbl1hal8gnsu